EP
MRK icon

Eversept Partners’s Merck MRK Stock Holding History

Eversept Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-48,700
Closed -$5.4M – 73
2022
Q4 		$5.4M Hold
48,700
– – 0.47% 38
2022
Q3 		$4.19M Hold
48,700
– – 0.36% 38
2022
Q2 		$4.44M Hold
48,700
– – 0.32% 49
2022
Q1 		$4M Hold
48,700
– – 0.31% 52
2021
Q4 		$3.73M Hold
48,700
– – 0.24% 67
2021
Q3 		$3.66M Hold
48,700
– – 0.25% 59
2021
Q2 		$3.79M Buy
+48,700
New +$3.62M 0.25% 54

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eversept Partners's MRK Position: Q2 2022 in Review

Eversept Partners sold out of Merck (MRK) in Q2 2022, closing a stake of 9,483 shares — an estimated $841K sold.

Eversept Partners first reported a position in MRK in Q3 2018 and held it in 4 quarters. The position peaked at $10.6M in Q3 2018. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Eversept Partners reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
  • Eversept Partners sold 9,483 Merck shares in Q2 2022, an estimated $841K.
  • Eversept Partners first reported a position in Merck in Q3 2018 and held it in 4 quarters.
  • Eversept Partners's Merck position peaked at $10.6M in Q3 2018.
  • 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.